{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:01:30Z","timestamp":1779328890814,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2435,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cardiac fibrosis is associated with left ventricular (LV) remodelling and contractile dysfunction in aortic stenosis (AS). The fibrotic process in this condition is still unclear. The aim of this study was to determine the role of both local and systemic inflammation as underlying mechanisms of LV fibrosis and contractile dysfunction. The diagnostic values of 2D-strain echocardiography and serum biomarkers in the evaluation of cardiac fibrosis in this condition were assessed through correlation analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Patients with AS referred for surgical valve replacement were prospectively and consecutively included. They all had a comprehensive echocardiography including 2D strain. Blood samples were collected to measure cytokines and inflammatory biomarkers using Luminex bead-based assays. A per-surgical myocardial biopsy of the basal antero-septal segment (S1) was performed. Serial sections of each biopsy were stained with Sirius red. Digital image analysis was used to quantify fibrosis. Immunostainings using specific antibodies against macrophage, glycoprotein (gp) 130, and interleukin 6 (IL-6) were also performed. Patients were divided into tertiles reflecting the severity of fibrosis: mild, moderate, and severe load (TF1 to TF3). The mean age of the 58 included patients was 73 \u00b1 11 years. Twenty-four (43%) were in New York Heart Association III\u2013IV. Mean aortic valve area was 0.8 \u00b1 0.2 cm2. Mean aortic stenosis peak velocity and mean gradient were respectively 4.5 \u00b1 0.8 m\/s and 54 \u00b1 15 mmHg. The mean LV ejection fraction was 54 \u00b1 12%, and the global LV longitudinal strain was \u221215 \u00b1 4%. The mean S1 strain, corresponding to the biopsied region, was \u221210 \u00b1 6% and was strongly correlated to fibrosis load (R = 0.83, P &amp;lt; 0.0001). TF3 was associated with higher mortality (P = 0.009), higher serum C-reactive protein and IL-6, and lower gp130 compared with the other tertiles (P &amp;lt; 0.05). IL-6 and gp130 were expressed in the heart and respectively in the plasma membrane of macrophages and in the cytoplasm of both macrophages and cardiomyocytes. During follow-up, three patients died and were all in the third fibrosis tertile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found a positive correlation between elevated inflammatory markers and degree of fibrosis load. These two parameters were associated with worse outcomes in patients with severe AS. Our results may be of interest especially in patients for whom a transcatheter aortic valve implantation is indicated and myocardial biopsy is not possible. Strategies aiming at preventing inflammation might be considered to decrease or limit the progression of cardiac fibrosis in patients followed for AS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12451","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T03:58:42Z","timestamp":1558497522000},"page":"649-657","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Causes and Consequences of Cardiac Fibrosis in Patients Referred for Surgical Aortic Valve Replacement"],"prefix":"10.1093","volume":"6","author":[{"given":"Arnault","family":"Galat","sequence":"first","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Guellich","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Bodez","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Lipskaia","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Moutereau","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Biochemistry, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Bergoend","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiovascular Surgery, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"H\u00fce","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Immunology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Ternacle","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dania","family":"Mohty","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dupuytren Hospital, CHU Limoges, P\u00f4le C\u0153ur-Poumon-Rein , Limoges ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Monin","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Derumeaux","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"GRC Amyloid Research Institute, IMRB\/INSERM U955 , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costin","family":"Radu","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiovascular Surgery, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[{"name":"UPEC, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"Department of Cardiology, AP-HP, Henri-Mondor Teaching Hospital , Cr\u00e9teil ,","place":["France"]},{"name":"D\u00e9partement Hospitalo-Universitaire Ageing Thorax-Vessels-Blood (DHU ATVB) , Cr\u00e9teil ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"2026012115093154800_ehf212451-bib-0001","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C","year":"2012","journal-title":"Eur Heart J"},{"key":"2026012115093154800_ehf212451-bib-0002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.athoracsur.2004.02.020","article-title":"Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis","volume":"78","author":"Sharma","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"2026012115093154800_ehf212451-bib-0003","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","article-title":"Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis","volume":"120","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"2026012115093154800_ehf212451-bib-0004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"Azevedo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026012115093154800_ehf212451-bib-0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0008-6363(98)00305-8","article-title":"Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors","volume":"41","author":"Nicoletti","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2026012115093154800_ehf212451-bib-0006","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"2026012115093154800_ehf212451-bib-0007","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.amjcard.2005.11.086","article-title":"Relations of inflammation and novel risk factors to valvular calcification","volume":"97","author":"Fox","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026012115093154800_ehf212451-bib-0008","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ Res"},{"key":"2026012115093154800_ehf212451-bib-0009","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"2026012115093154800_ehf212451-bib-0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2026012115093154800_ehf212451-bib-0011","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ Res"},{"key":"2026012115093154800_ehf212451-bib-0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.109.207456","article-title":"Intramyocardial fibroblast myocyte communication","volume":"106","author":"Kakkar","year":"2010","journal-title":"Circ Res"},{"key":"2026012115093154800_ehf212451-bib-0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-9149(96)00229-9","article-title":"Normalization of left ventricular nonuniformity late after valve replacement for aortic stenosis","volume":"78","author":"Villari","year":"1996","journal-title":"Am J Cardiol"},{"key":"2026012115093154800_ehf212451-bib-0014","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCRESAHA.110.227421","article-title":"Enhanced fibroblast-myocyte interactions in response to cardiac injury","volume":"107","author":"Vasquez","year":"2010","journal-title":"Circ Res"},{"key":"2026012115093154800_ehf212451-bib-0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00380-008-1128-8","article-title":"Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction","volume":"24","author":"Tan","year":"2009","journal-title":"Heart Vessels"},{"key":"2026012115093154800_ehf212451-bib-0016","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00380-004-0770-z","article-title":"Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure","volume":"19","author":"Hirota","year":"2004","journal-title":"Heart Vessels"},{"key":"2026012115093154800_ehf212451-bib-0017","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.172.9.5676","article-title":"Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms","volume":"172","author":"McLoughlin","year":"2004","journal-title":"J Immunol"},{"key":"2026012115093154800_ehf212451-bib-0018","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","article-title":"IL-6 switches the differentiation of monocytes from dendritic cells to macrophages","volume":"1","author":"Chomarat","year":"2000","journal-title":"Nat Immunol"},{"key":"2026012115093154800_ehf212451-bib-0019","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","article-title":"Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses","volume":"268","author":"Jostock","year":"2001","journal-title":"Eur J Biochem"},{"key":"2026012115093154800_ehf212451-bib-0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V82.4.1120.1120","article-title":"Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130","volume":"82","author":"Narazaki","year":"1993","journal-title":"Blood"},{"key":"2026012115093154800_ehf212451-bib-0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0092-8674(00)80729-1","article-title":"Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress","volume":"97","author":"Hirota","year":"1999","journal-title":"Cell"},{"key":"2026012115093154800_ehf212451-bib-0022","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.92.11.4862","article-title":"Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice","volume":"92","author":"Hirota","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012115093154800_ehf212451-bib-0023","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2015.04.014","article-title":"Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction","volume":"240","author":"Moreno Velasquez","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026012115093154800_ehf212451-bib-0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCULATIONAHA.109.933127","article-title":"Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction","volume":"122","author":"Hilfiker-Kleiner","year":"2010","journal-title":"Circulation"},{"key":"2026012115093154800_ehf212451-bib-0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1011401825680","article-title":"The role of interleukin-6 in the failing heart","volume":"6","author":"Wollert","year":"2001","journal-title":"Heart Fail Rev"},{"key":"2026012115093154800_ehf212451-bib-0026","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","article-title":"Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload","volume":"120","author":"Takeda","year":"2010","journal-title":"J Clin Invest"},{"key":"2026012115093154800_ehf212451-bib-0027","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp130 and the interleukin-6 family of cytokines","volume":"15","author":"Taga","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"2026012115093154800_ehf212451-bib-0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem J"},{"key":"2026012115093154800_ehf212451-bib-0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40259-013-0076-8","article-title":"Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis","volume":"28","author":"Dhillon","year":"2014","journal-title":"BioDrugs"},{"key":"2026012115093154800_ehf212451-bib-0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1373\/clinchem.2007.098608","article-title":"Association of serum interleukin-6 concentration with a functional IL6-6331T&gt;C polymorphism","volume":"54","author":"Smith","year":"2008","journal-title":"Clin Chem"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12451","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/4\/649\/66136489\/eschf_6_4_649.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/4\/649\/66136489\/eschf_6_4_649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:12:19Z","timestamp":1769026339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/4\/649\/8403569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,5,21]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12451","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"2018-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}